Ir para o conteúdo principal Ir para o menu de navegação principal Ir para o rodapé
Ciências da Saúde
Publicado: 2024-06-28

Overweight/obesity aggravates hospital complications in hospitalized patients with COVID-19: a systematic review

Universidade Federal do Mato Grosso - Campus Sinop
Universidade Federal do Mato Grosso - Campus Sinop
Universidade Federal do Mato Grosso - Campus Sinop
Universidade Federal do Mato Grosso - Campus Sinop
Universidade Federal do Mato Grosso - Campus Sinop
Universidade Federal do Mato Grosso - Campus Sinop
Universidade Federal do Mato Grosso - Campus Sinop
Universidade Federal do Mato Grosso - Campus Sinop
Overweight, Obesity, Coronavirus disease, COVID-19, Comorbidities


Coronavirus disease (COVID-19) has become a pandemic and patients with overweight and obesity have been reported to be at increased risk for complications from COVID-19. In this context, the objective of the present systematic review was to demonstrate the evidence relating the association or not of overweight and obesity with the prevalence of complications and worst prognosis in hospitalized COVID-19 patients. PubMed, Scielo, Lilacs, JMIR, ScienceDirect, Springer, Wiley and Web of Science were used to identify studies published in the period from 2020 to 2021.  This work was conducted based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and PICOS approach. The review included non-randomized or randomized controlled clinical trials, cohort, case-control, cross-sectional and observational studies, and the patient’s included in the studies should present overweight or obesity and COVID-19. From 395 articles, 49 studies met the scope of the review and were selected to be evaluated in this systematic review. According to the selected articles, it was observed that most patients hospitalized with COVID-19 were overweight/obese, elderly (mean age between 60 and 65 years old) and male. Overweight and obesity significantly contributed to increase the incidence of complications as longer hospital stay, invasive mechanical ventilation, non-invasive ventilation, kidney injury, septic shock, heart injury and ICU admission, increasing the rate of deaths. It was observed that the overweight and obesity significantly contributed to increase the incidence of complications and promote a worst prognosis in those patients, being present in most hospital complications.


  1. AL‐SABAH, Salman; AL‐HADDAD, Mohannad; AL‐YOUHA, Sarah; JAMAL, Mohammad; ALMAZEEDI, Sulaiman. COVID ‐19: Impact of obesity and diabetes on disease severity. Clinical Obesity, [S. l.], v. 10, n. 6, 2020. DOI: 10.1111/cob.12414.
  2. ALBASHIR, Ahmed Abdalazim Dafallah. The potential impacts of obesity on COVID-19. Clinical Medicine, Journal of the Royal College of Physicians of London, [S. l.], v. 20, n. 4, p. E109–E113, 2020. DOI: 10.7861/CLINMED.2020-0239.
  3. ALMEIDA, Joelson Dos Santos; CARDOSO, Jonas Alves; CORDEIRO, Eduardo Costa; LEMOS, Messias; DE ARAÚJO, Telma Maria Evangelista; SARDINHA, Ana Hélia De Lima. EPIDEMIOLOGICAL CHARACTERIZATION OF COVID-19 CASES IN MARANHÃO: A BRIEF ANALYSIS. Revista Prevenção de Infecção e Saúde, [S. l.], v. 6, 2020. DOI: 10.26694/repis.v6i0.10477.
  4. ARBEL, Yuval; FIALKOFF, Chaim; KERNER, Amichai; KERNER, Miryam. Can reduction in infection and mortality rates from coronavirus be explained by an obesity survival paradox? An analysis at the US statewide level. International Journal of Obesity, [S. l.], v. 44, n. 11, p. 2339–2342, 2020. DOI: 10.1038/S41366-020-00680-7.
  5. ASSELAH, Tarik; DURANTEL, David; PASMANT, Eric; LAU, George; SCHINAZI, Raymond F. COVID-19: Discovery, diagnostics and drug developmentJournal of HepatologyElsevier B.V., , 2021. DOI: 10.1016/j.jhep.2020.09.031.
  6. BELASCO, A. G. S.; FONSECA, C. D. Coronavirus 2020. Revista brasileira de enfermagem, [S. l.], v. 73, n. 2, 2020. DOI: 10.1590/0034-7167-2020730201.
  7. BETTINI, Silvia; BUCCA, Giovanni; SENSI, Caterina; DAL PRÀ, Chiara; FABRIS, Roberto; VETTOR, Roberto; BUSETTO, Luca. Higher levels of C-reactive protein and ferritin in patients with overweight and obesity and SARS-CoV-2-related pneumonia. Obesity Facts, [S. l.], v. 14, n. 5, p. 543–549, 2021. DOI: 10.1159/000517851.
  8. BIHAN, Hélène et al. Epicardial adipose tissue and severe Coronavirus Disease 19. Cardiovascular Diabetology, [S. l.], v. 20, n. 1, 2021. DOI: 10.1186/S12933-021-01329-Z/FULLTEXT.HTML.
  9. BISCARINI, Simona et al. The obesity paradox: Analysis from the SMAtteo COvid-19 REgistry (SMACORE) cohort. Nutrition, Metabolism and Cardiovascular Diseases, [S. l.], v. 30, n. 11, p. 1920–1925, 2020. DOI: 10.1016/J.NUMECD.2020.07.047.
  10. BOLSONI-LOPES, Andressa; FURIERI, Lorena; ALONSO-VALE, Maria Isabel Cardoso. Obesity and covid-19: a reflection on the relationship between pandemics. Revista gaucha de enfermagem, [S. l.], v. 42, n. spe, p. e20200216, 2021. DOI: 10.1590/1983-1447.2021.20200216.
  11. BUSETTO, Luca; BETTINI, Silvia; FABRIS, Roberto; SERRA, Roberto; DAL PRA, Chiara; MAFFEI, Pietro; ROSSATO, Marco; FIORETTO, Paola; VETTOR, Roberto. Obesity and COVID-19: An Italian Snapshot. Obesity, [S. l.], v. 28, n. 9, p. 1600–1605, 2020. DOI: 10.1002/oby.22918.
  12. CAI, Huan et al. High body mass index is a significant risk factor for the progression and prognosis of imported COVID-19: a multicenter, retrospective cohort study. BMC Infectious Diseases, [S. l.], v. 21, n. 1, 2021. DOI: 10.1186/S12879-021-05818-0/FULLTEXT.HTML.
  13. CARNEIRO, Raquel Alencastro Veiga Domingues; HILLESHEIM, Danúbia; HALLAL, Ana Luiza Curi. Correlation of overweight condition and obesity with mortality by COVID-19 in Brazil’s state capitals. Archives of Endocrinology and Metabolism, [S. l.], v. 65, p. 386–391, 2021.
  14. CHEN, Vincent L. et al. Hepatic Steatosis Is Associated with Increased Disease Severity and Liver Injury in Coronavirus Disease-19. Digestive Diseases and Sciences, [S. l.], v. 66, n. 9, p. 3192–3198, 2021. DOI: 10.1007/S10620-020-06618-3.
  15. CHIUMELLO, Davide; POZZI, Tommaso; STORTI, Enrico; CACCIOPPOLA, Alessio; PONTIROLI, Antonio E.; COPPOLA, Silvia. Body mass index and acute respiratory distress severity in patients with and without SARS-CoV-2 infection. British Journal of Anaesthesia, [S. l.], v. 125, n. 4, p. e376–e377, 2020. DOI: 10.1016/J.BJA.2020.07.006.
  16. COSS-ROVIROSA, Maria Fernanda; AGUILAR-SOTO, Mercedes; CUENCA, Dalia; VELEZ-PINTADO, Mariana; CAMIRO-ZUÑIGA, Antonio; FERREIRA-HERMOSILLO, Aldo; MERCADO, Moises. Are overweight and obesity risk factors for invasive mechanical ventilation in severe coronavirus disease 2019 pneumonia? Archives of Endocrinology and Metabolism, [S. l.], 2021. DOI: 10.20945/2359-3997000000350.
  17. EASTMENT, McKenna C. et al. BMI and Outcomes of SARS-CoV-2 Among US Veterans. Obesity, [S. l.], v. 29, n. 5, p. 900–908, 2021. DOI: 10.1002/oby.23111.
  18. HAJIFATHALIAN, Kaveh et al. Obesity is Associated with Worse Outcomes in COVID-19: Analysis of Early Data from New York City. Obesity, [S. l.], v. 28, n. 9, p. 1606–1612, 2020. DOI: 10.1002/OBY.22923.
  19. HEALY, Katie et al. Salivary IgG to SARS-CoV-2 indicates seroconversion and correlates to serum neutralization in mRNA-vaccinated immunocompromised individuals. Med, [S. l.], v. 3, n. 2, p. 137- 153.e3, 2022. DOI: 10.1016/j.medj.2022.01.001.
  20. HUANG, Yi; LU, Yao; HUANG, Yan Mei; WANG, Min; LING, Wei; SUI, Yi; ZHAO, Hai Lu. Obesity in patients with COVID-19: a systematic review and meta-analysis. Metabolism: Clinical and Experimental, [S. l.], v. 113, 2020. DOI: 10.1016/j.metabol.2020.154378.
  21. IANNELLI, Antonio; BOUAM, Samir; SCHNECK, Anne Sophie; FREY, Sébastien; ZARCA, Kevin; GUGENHEIM, Jean; ALIFANO, Marco. The Impact of Previous History of Bariatric Surgery on Outcome of COVID-19. A Nationwide Medico-Administrative French Study. Obesity Surgery, [S. l.], v. 31, n. 4, p. 1455–1463, 2021. DOI: 10.1007/S11695-020-05120-Z/FULLTEXT.HTML.
  22. KAMYARI, Naser; SOLTANIAN, Ali Reza; MAHJUB, Hossein; MOGHIMBEIGI, Abbas. Diet, nutrition, obesity, and their implications for COVID-19 mortality: Development of a marginalized two-part model for semicontinuous data. JMIR Public Health and Surveillance, [S. l.], v. 7, n. 1, 2021. DOI: 10.2196/22717.
  23. KIM, Tara S.; ROSLIN, Mitchell; WANG, Jason J.; KANE, Jamie; HIRSCH, Jamie S.; KIM, Eun Ji. BMI as a Risk Factor for Clinical Outcomes in Patients Hospitalized with COVID-19 in New York. Obesity, [S. l.], v. 29, n. 2, p. 279–284, 2021. DOI: 10.1002/OBY.23076.
  24. LAUER, Stephen A.; GRANTZ, Kyra H.; BI, Qifang; JONES, Forrest K.; ZHENG, Qulu; MEREDITH, Hannah R.; AZMAN, Andrew S.; REICH, Nicholas G.; LESSLER, Justin. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Annals of internal medicine, [S. l.], v. 172, n. 9, p. 577–582, 2020. DOI: 10.7326/M20-0504.
  25. MALAVAZOS, Alexis Elias et al. Abdominal obesity phenotype is associated with COVID-19 chest X-ray severity score better than BMI-based obesity. Eating and Weight Disorders, [S. l.], 2021. DOI: 10.1007/S40519-021-01173-W/FULLTEXT.HTML.
  27. MARTÍN-DEL-CAMPO, Fabiola et al. Morbid obesity is associated with mortality and acute kidney injury in hospitalized patients with COVID-19. Clinical nutrition ESPEN, [S. l.], v. 45, p. 200–205, 2021. a. DOI: 10.1016/j.clnesp.2021.08.027.
  28. MARTÍN-DEL-CAMPO, Fabiola et al. Morbid obesity is associated with mortality and acute kidney injury in hospitalized patients with COVID-19. Clinical Nutrition ESPEN, [S. l.], v. 45, p. 200–205, 2021. b. DOI: 10.1016/J.CLNESP.2021.08.027.
  29. MOHER, David; LIBERATI, Alessandro; TETZLAFF, Jennifer; ALTMAN, Douglas G.; LIBERATI, A.; ALTMAN, D. G. Reprint-Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. [s.l: s.n.].
  30. MORICONI, Diego; MASI, Stefano; REBELOS, Eleni; VIRDIS, Agostino; MANCA, Maria Laura; DE MARCO, Salvatore; TADDEI, Stefano; NANNIPIERI, Monica. Obesity prolongs the hospital stay in patients affected by COVID-19, and may impact on SARS-COV-2 shedding. Obesity Research and Clinical Practice, [S. l.], v. 14, n. 3, p. 205–209, 2020. DOI: 10.1016/J.ORCP.2020.05.009.
  31. NAKESHBANDI, Mohamed et al. The impact of obesity on COVID-19 complications: a retrospective cohort study. International Journal of Obesity, [S. l.], v. 44, n. 9, p. 1832–1837, 2020. DOI: 10.1038/s41366-020-0648-x.
  32. OLIVAS-MARTÍNEZ, Antonio et al. In-hospital mortality from severe COVID-19 in a tertiary care center in Mexico City; causes of death, risk factors and the impact of hospital saturation. PLoS ONE, [S. l.], v. 16, n. 2 February, 2021. DOI: 10.1371/JOURNAL.PONE.0245772.
  33. OSUNA-PADILLA, Iván Armando; RODRÍGUEZ-MOGUEL, Nadia Carolina; AGUILAR-VARGAS, Adriana; RODRÍGUEZ-LLAMAZARES, Sebastián. High nutritional risk using NUTRIC-Score is associated with worse outcomes in COVID-19 critically ill patients. Nutricion hospitalaria, [S. l.], v. 38, n. 3, p. 540–544, 2021. DOI: 10.20960/NH.03440.
  34. PAGE-WILSON, Gabrielle et al. Obesity is independently associated with septic shock, renal complications, and mortality in a multiracial patient cohort hospitalized with COVID-19. PLoS ONE, [S. l.], v. 16, n. 8 August, 2021. DOI: 10.1371/journal.pone.0255811.
  35. PAGE, Matthew J. et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviewsThe BMJBMJ Publishing Group, , 2021. DOI: 10.1136/bmj.n71.
  36. PETERSEN, Antonia et al. The role of visceral adiposity in the severity of COVID-19: Highlights from a unicenter cross-sectional pilot study in Germany. Metabolism: Clinical and Experimental, [S. l.], v. 110, 2020. DOI: 10.1016/J.METABOL.2020.154317.
  37. PIETRI, Léa et al. Excess body weight is an independent risk factor for severe forms of COVID-19. Metabolism: Clinical and Experimental, [S. l.], v. 117, 2021. DOI: 10.1016/J.METABOL.2021.154703.
  38. QUEIROZ, Eveline Aparecida Isquierdo Fonseca; CARNEIRO, Polyana Bárbara Freese; BRAZ, Karen Nayara de Souza; ASSUNÇÃO, Gabriel Sousa Almeida; OLIVEIRA, Camila Costa De; LAMPUGNANI, Lucas Delfino; RODRIGUES, Evelyn Evelyn Angrevski; QUEIROZ, Diogo Albino De; ALEGRANCI, Pâmela. Obesidade e câncer: mecanismos envolvidos e intervenções terapêuticas. Scientific Electronic Archives, [S. l.], v. 15, n. 3, 2022. DOI: 10.36560/15320221522. Disponível em: Acesso em: 24 jun. 2022.
  39. QURESHI, Ali; SULAIMAN, Syed Azhar Bin Syed; QURESHI, Pir Abdul Ahad Aziz; BHUTTO, Mehwish. Obesity as a Predominant Factor in Covid-19 Mortality; Relationship between Increased BMI and Mortality in Covid-19. Journal of Pharmaceutical Research International, [S. l.], p. 8–15, 2021. DOI: 10.9734/JPRI/2021/V33I27B31497.
  40. ROBERTSON, Josefina et al. BMI in early adulthood is associated with severe COVID‐19 later in life – a prospective cohort study of 1.5 million Swedish men. Obesity, [S. l.], 2022. DOI: 10.1002/OBY.23378.
  41. ROD, J. E.; OVIEDO-TRESPALACIOS, Oscar; CORTES-RAMIREZ, Javier. A brief-review of the risk factors for covid-19 severity. Revista de Saude Publica, [S. l.], v. 54, 2020. DOI: 10.11606/S1518-8787.2020054002481.
  42. SAHIN, Serdar et al. The role of obesity in predicting the clinical outcomes of COVID-19. Obesity Facts, [S. l.], v. 14, n. 5, p. 481–489, 2021. DOI: 10.1159/000517180.
  43. SARMADI, Mohammad; AHMADI-SOLEIMANI, S. Mohammad; FARAROUEI, Mohammad; DIANATINASAB, Mostafa. COVID-19, body mass index and cholesterol: an ecological study using global data. BMC Public Health, [S. l.], v. 21, n. 1, 2021. DOI: 10.1186/S12889-021-11715-7/FULLTEXT.HTML.
  44. SILVA, Giordana Maronezzi Da; PESCE, Giovanna Brichi; MARTINS, Débora Cristina; CARREIRA, Lígia; FERNANDES, Carlos Alexandre Molena; JACQUES, André Estevam. Obesidade como fator agravante da COVID-19 em adultos hospitalizados: revisão integrativa. Acta Paulista de Enfermagem, [S. l.], v. 34, p. eAPE02321, 2021. DOI: 10.37689/ACTA-APE/2021AR02321.
  45. SIMONNET, Arthur et al. High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Requiring Invasive Mechanical Ventilation. Obesity, [S. l.], v. 28, n. 7, p. 1195–1199, 2020. DOI: 10.1002/oby.22831.
  46. WANG, Jian et al. Overweight and Obesity are Risk Factors of Severe Illness in Patients with COVID-19. Obesity, [S. l.], v. 28, n. 11, p. 2049–2055, 2020. DOI: 10.1002/oby.22979.
  47. WANG, Jingzhou; SATO, Toshiro; SAKURABA, Atsushi. Coronavirus disease 2019 (COVID-19) meets obesity: Strong association between the global overweight population and COVID-19 mortality. Journal of Nutrition, [S. l.], v. 151, n. 1, p. 9–10, 2021. DOI: 10.1093/jn/nxaa375.
  48. YAN, Huadong et al. Serum glucose, lactate dehydrogenase and hypertension are mediators of the effect of body mass index on severity of COVID-19. Endocrinology, Diabetes and Metabolism, [S. l.], v. 4, n. 2, 2021. DOI: 10.1002/EDM2.215.
  49. YANOVER, Chen; MIZRAHI, Barak; KALKSTEIN, Nir; MARCUS, Karni; AKIVA, Pinchas; BARER, Yael; SHALEV, Varda; CHODICK, Gabriel. What factors increase the risk of complications in SARS-CoV-2–infected patients? A cohort study in a nationwide Israeli Health Organization. JMIR Public Health and Surveillance, [S. l.], v. 6, n. 3, 2020. DOI: 10.2196/20872.
  50. YU, Wanqi; ROHLI, Kristen E.; YANG, Shujuan; JIA, Peng. Impact of obesity on COVID-19 patientsJournal of Diabetes and its ComplicationsElsevier Inc., , 2021. DOI: 10.1016/j.jdiacomp.2020.107817.
  51. ZHANG, Yang et al. The clinical characteristics and outcomes of patients with diabetes and secondary hyperglycaemia with coronavirus disease 2019: A single-centre, retrospective, observational study in Wuhan. Diabetes, Obesity and Metabolism, [S. l.], v. 22, n. 8, p. 1443–1454, 2020. DOI: 10.1111/DOM.14086.
  52. ZHOU, Peng et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, [S. l.], v. 579, n. 7798, p. 270–273, 2020. DOI: 10.1038/s41586-020-2012-7.
  53. ZHU, Na et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. New England Journal of Medicine, [S. l.], v. 382, n. 8, p. 727–733, 2020. a. DOI: 10.1056/nejmoa2001017.
  54. ZHU, Zhaozhong; HASEGAWA, Kohei; MA, Baoshan; FUJIOGI, Michimasa; CAMARGO, Carlos A.; LIANG, Liming. Association of obesity and its genetic predisposition with the risk of severe COVID-19: Analysis of population-based cohort data. Metabolism: Clinical and Experimental, [S. l.], v. 112, 2020. b. DOI: 10.1016/j.metabol.2020.154345.

Como Citar

Santos, K. K. P. M. dos, Mattar, V. T. R., Costa, F. C. de O., Garcia, R. M., Breno Marcos Brito do, Cabral, M. A. A. S. K., … Queiroz, E. A. I. F. de. (2024). Overweight/obesity aggravates hospital complications in hospitalized patients with COVID-19: a systematic review. Scientific Electronic Archives, 17(4).